Day: July 29, 2020

2020 second quarterPress release – Paris, July 29, 2020Sales strongly impacted by Covid-19, as anticipatedGradual sales improvement throughout quarterMainland China back to growth in JuneQ2 2020 sales down -45.8% as reported; -47.0% on an organic1 basisMainland China sales continued to gradually improve throughout Q2 2020, returning to sales growth in JuneStrong digital acceleration in all regions (+32.0% of sales growth2)Solid execution, in H1 2020, of the action plan to mitigate the impact of crisis:Capex: meaningful reductionOpex: Variabilization of 50% of total costsInventories: Reduction of FW20 purchases by more than 30%Cash: signature of €140m state guaranteed loan and additional flexibility on 2020-21 financial covenantsSelective openings: +8 DOS in Q2 2020             Commenting on the report, Daniel Lalonde, SMCP’s CEO,...

Deuxième trimestre 2020Communiqué – Paris, le 29 juillet 2020Covid-19 : impact significatif sur le chiffre d’affaires, comme anticipéAmélioration progressive des ventes au cours du trimestreReprise de la croissance, en juin, en Chine continentaleChiffre d’affaires T2 2020 en baisse de -45,8% en données publiées ; -47.0% en organique1Poursuite de l’amélioration progressive des ventes en Chine continentale au cours du T2 2020 ; reprise de la croissance des ventes en juinForte accélération de l’e-commerce dans l’ensemble des régions (+32,0% de croissance2 du chiffre d’affaires)Solide exécution du plan d’actions au S1 2020 pour atténuer les effets de la crise :Capex : réduction significativeOpex : variabilisation de 50% des coûts totauxStocks : réduction de plus de 30% des achats sur les collections AH20Trésorerie : signature...

LEAWOOD, Kansas, July 29, 2020 (GLOBE NEWSWIRE) — Euronet Worldwide, Inc. (“Euronet” or the “Company”) (NASDAQ: EEFT), a leading electronic payments provider, reports second quarter 2020 financial results.Euronet reports the following consolidated results for the second quarter 2020 compared with the same period of 2019:Revenues of $527.8 million, a 24% decrease from $691.9 million (22% decrease on a constant currency(1) basis).Operating loss of ($101.3) million, compared to operating income of $117.9 million.Adjusted operating income(2) of $3.3 million (excluding a $104.6 million impairment of goodwill), a 97% decrease from $116.6 million (excluding a $1.3 million post-acquisition adjustment) (98% decrease on a constant currency basis).Net loss attributable to Euronet of ($115.8) million or ($2.18) diluted loss per share, compared...

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATESTORONTO, July 28, 2020 (GLOBE NEWSWIRE) — QuestCap Inc. (“QuestCap” or the “Company”) (CSE:QSC; FRA:34C1) is pleased to announce that it has entered into an arm’s-length definitive agreement (the “Agreement”) with Latin-Canada Pharma Inc. (Canada) (the “Vendor”) and Latin-Canada Pharma Inc. (Bahamas) (“LCP Bahamas”) and has closed the transaction to acquire a 28% indirect equity interest in Sanaty IPS S.A.S. (“Sanaty”), a full-service medical clinic in Colombia (the “Transaction”). For more information on Sanaty, please see the Company’s press release dated July 9, 2020, which is available under the Company’s SEDAR profile at www.sedar.com.Pursuant to the Agreement, QuestCap has acquired from the Vendor a 40% interest in LCP Bahamas...

HOUSTON, July 28, 2020 (GLOBE NEWSWIRE) — Greenfields Petroleum Corporation (the “Corporation” or “Greenfields”) (TSX VENTURE: GNF), a production focused company with operating assets in Azerbaijan, announces its financial and operating results for the three months and year ended December 31, 2019  and for the three months ended March 31, 2020. The Corporation also announces the extension of senior secured debt payments and forbearance of senior lender’s previously announced repayment demand and extension to the protocol (the “Protocol”) in respect of the carry of certain costs and related issues between Bahar Energy Limited (“BEL”), a wholly owned subsidiary of the Corporation and the State Oil Company of Azerbaijan (“SOCAR”).Selected financial and operational information included below should be read in conjunction with the Corporation’s...

NEW HAVEN, Conn., July 28, 2020 (GLOBE NEWSWIRE) — BioXcel Therapeutics, Inc. (“BTI” or the “Company”) (Nasdaq: BTAI), a clinical-stage biopharmaceutical development company, today announced the pricing of an underwritten public offering of 4,000,000 shares of common stock at a public offering price of $50.00 per share. In addition, certain selling stockholders have granted the underwriters a 30-day option to purchase up to an additional 600,000 shares of common stock at the public offering price, less underwriting discounts and commissions. Gross proceeds to BTI from the offering are expected to be $200 million, before deducting underwriting discounts and commissions and offering expenses. The Company will not receive any of the proceeds from any sale of shares in this offering by the selling stockholders. BofA Securities, Goldman...

CAMBRIDGE, Mass., July 28, 2020 (GLOBE NEWSWIRE) — TCR2 Therapeutics Inc. (Nasdaq: TCRR) (“TCR2” or the “Company”), a clinical-stage immunotherapy company with a pipeline of novel T cell therapies for patients suffering from cancer, today announced the pricing of an underwritten public offering of 8,000,000 shares of its common stock at a public offering price of $15.50 per share. TCR2 also granted the underwriters a 30-day option to purchase up to an additional 1,200,000 shares of common stock at the public offering price, less the underwriting discounts and commissions. The gross proceeds from the offering, before deducting underwriting discounts and commissions and offering expenses payable by the Company, are expected to be $124.0 million, excluding any exercise of the underwriters’ option to purchase additional shares. All...